Pharma CEOs

Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Regeneron
Allergan
Pharma CEOs
Leonard Schleifer
Pfizer
patents
Restasis
Flag link:
Incoming Novartis CEO On $475,000 Cancer Therapy: 'No Question That The List Price Raises Eyebrows'
Incoming Novartis CEO On $475,000 Cancer Therapy: 'No Question That The List Price Raises Eyebrows'
Forbes
Novartis
drug pricing
cancer
Kymriah
Pharma CEOs
Vas Narasimhan
Flag link:
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Endpoints
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
R&D
executives
Flag link:
What to expect from Vas Narasimhan, next Novartis CEO
What to expect from Vas Narasimhan, next Novartis CEO
GoinPharma
Novartis
Pharma CEOs
Vas Narasimhan
Flag link:
Pfizer unveils plan to replace Ian Read
Pfizer unveils plan to replace Ian Read
GoinPharma
Pfizer
Pharma CEOs
Ian Read
Albert Bourla
Flag link:
[forum discussion] Allergan employees discuss impending cost cuts announced by CEO Saunders
[forum discussion] Allergan employees discuss impending cost cuts announced by CEO Saunders
Cafepharma Message Boards
Allergan
Pharma CEOs
Brent Saunders
layoffs
Flag link:
After months of searching, Immunomedics lines up Celgene vet Pehl as its new CEO
After months of searching, Immunomedics lines up Celgene vet Pehl as its new CEO
Fierce Biotech
Immunomedics
Celgene
Pharma CEOs
Michael Pehl
Flag link:
You'll Be Stunned by Gilead Sciences CEO's Prediction for 2018
You'll Be Stunned by Gilead Sciences CEO's Prediction for 2018
Motley Fool
Gilead Sciences
John Milligan
Pharma CEOs
Flag link:
Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal
Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
patents
Restasis
Flag link:
Cost cuts are coming for Allergan, CEO says. But a breakup isn’t
Cost cuts are coming for Allergan, CEO says. But a breakup isn’t
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
layoffs
Flag link:
In a switch, Merck CEO signals he’s in a deal-making frame of mind
In a switch, Merck CEO signals he’s in a deal-making frame of mind
Endpoints
Merck
M&A
Pharma CEOs
Ken Frazier
Flag link:
Allergan defends Restasis deal by calling for review of patent challenge process
Allergan defends Restasis deal by calling for review of patent challenge process
Fierce Pharma
Allergan
Restasis
Pharma CEOs
patents
Brent Saunders
Flag link:
Lilly shakeup, the sequel: New CEO taps insiders to take reins from exiting execs
Lilly shakeup, the sequel: New CEO taps insiders to take reins from exiting execs
Fierce Pharma
Eli Lilly
Pharma CEOs
David Ricks
Flag link:
New pharma CEOs to face payer, pricing challenges
New pharma CEOs to face payer, pricing challenges
Medical Marketing and Media
Pharma CEOs
Novartis
Teva Pharmaceutical
Kåre Schultz
Vasant Narasimham
payers
drug pricing
Flag link:
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Teva CEO gets lots of advice on how to fix beleaguered company, even before he begins
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Flag link:
This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge
This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge
Stat
Pharma CEOs
Allergan
Brent Saunders
drug pricing
Restasis
Flag link:
Ex-Glaxo CEO Witty joins Hatteras as venture partner
Ex-Glaxo CEO Witty joins Hatteras as venture partner
Fierce Biotech
Pharma CEOs
GSK
Andrew Witty
Hatteras Venture Partners
Flag link:
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
Endpoints
GSK
Pharma CEOs
Emma Walmsley
vaccines
Shingrix
Zostavax
shingles
Flag link:
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Fierce Pharma
Teva Pharmaceutical
executive pay
Pharma CEOs
Lundbeck
Kåre Schultz
Flag link:
5 Things Regeneron's CEO Said as the Biotech Stock Sank
5 Things Regeneron's CEO Said as the Biotech Stock Sank
Motley Fool
Regeneron
Pharma CEOs
Leonard Schleifer
Sanofi
Dupixent
Flag link:

Pages